Form D/A — Nuclein, LLC
0001787352-26-000002 · filed Apr 27, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $25,000,000
- Reported amount sold
- $19,065,157
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nuclein, LLC
- CIK
- 1787352
- Entity
- Limited Liability Company
- Jurisdiction
- TEXAS
- Year incorporated
- —
- Address
- 8305 CROSS PARK DR
AUSTIN, Texas 78754 - Phone
- 512-879-3301
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alan Blake · Executive OfficerAustin, Texas Find on LinkedIn ↗
-
Richard Crockett · DirectorAustin, Texas Find on LinkedIn ↗
-
William Cunningham · DirectorAustin, Texas Find on LinkedIn ↗
-
Douglas Bryant · DirectorAustin, Texas Find on LinkedIn ↗
-
Sanjay Chandra · DirectorAustin, Texas Find on LinkedIn ↗
-
H. David Shockley · DirectorAustin, Texas Find on LinkedIn ↗
-
Walter Narajowski · DirectorAustin, Texas Find on LinkedIn ↗
-
Jeffrey Stukuls · Executive OfficerAustin, Texas Find on LinkedIn ↗
Other filings from this issuer
- Form D/A — Oct 27, 2026 — 0001787352-26-000005
- Form D/A — Aug 14, 2026 — 0001787352-26-000004
- Form D — Jun 22, 2026 — 0001787352-26-000003
- Form D/A — Feb 5, 2026 — 0001787352-26-000001
- Form D/A — Dec 17, 2025 — 0001787352-25-000006
- Form D/A — Oct 14, 2025 — 0001787352-25-000004
- Form D — Jun 30, 2025 — 0001787352-25-000002
- Form D — Feb 3, 2025 — 0001787352-25-000001
View the original filing on SEC EDGAR ↗